Content » Vol 81, Issue 1

Letter to the Editor

Epidermolysis Bullosa Acquisita Treated with Basiliximab, an Interleukin-2 Receptor Antibody

Michael G. Haufs, Eckart Haneke
DOI: 10.1080/000155501750208353

Abstract

This article does not have an abstract.

Significance

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.